CEO Total Pay
$274K
FY2021 Summary Compensation, below median
INVA FY2021 SEC EDGAR DEF 14A
Innoviva, Inc. CEO pay ratio
The CEO earned $274K in FY2021 against median worker pay of $274,407 · Chemicals & Pharmaceuticals.
- State
- DE
- Filing date
- 2022-03-25
- Industry
- Chemicals & Pharmaceuticals
- Fiscal year
- FY2021
Data updated August 2026
CEO-to-worker pay ratio
63:1
Moderate (Scale: 0–1000:1)
CEO pay
$274K
Median worker
$274,407
Latest filing FY2021. This company's newest DEF 14A on file is for FY2021, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Innoviva, Inc. reported a 63:1 CEO-to-worker pay ratio in FY2021 - above the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
- Pay ratio
- 63:1
- FY2021 disclosed
- CEO total
- $274K
- Summary Compensation Table total
- Median worker
- $274,407
- Dodd-Frank median employee
Ratio bands among Chemicals & Pharmaceuticals peers
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2021
A component-level pay breakdown is not reported in Innoviva, Inc.'s structured SEC pay-ratio disclosure. See our methodology →
Industry Comparison - Chemicals & Pharmaceuticals
This Company's Ratio
63:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$274K
Companies in Industry
168
vs. Industry Median
Above
Innoviva, Inc.: MODEST · MICRO pay ratio
Innoviva, Inc. disclosed 63:1 CEO-to-worker pay and $274K CEO total in FY2021. the CEO earned 63× the median employee ($274,407) in FY2021.
Median employee $274,407 (ELITE-MED); MODEST · MICRO stamps put about 63 median-wage years per CEO year.
Pay Ratio
63:1
Near industry median
What FY2021 shows for Innoviva, Inc.
Innoviva, Inc. disclosed 63:1 CEO-to-worker pay and $274K CEO total in FY2021. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Innoviva, Inc.'s $274K CEO total is at or below the $7.9M industry median CEO pay.
Innoviva, Inc. stamps MODEST · MICRO · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Key Data, FY2021
- Total Compensation
- $274K
- Median Employee Pay
- $274,407
- Pay Ratio
- 63:1
- Filing Date
- 2022-03-25
Company Info
- Ticker
- INVA
- CIK
- 1080014
- Industry
- Chemicals & Pharmaceuticals
- SIC Code
- 2834
- State
- DE
SEC EDGAR DEF 14A for CIK 1080014, FY2021. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. Innoviva, Inc. disclosed 63:1 CEO-to-worker pay and $274K CEO total in FY2021.
Read with Innoviva, Inc.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MICRO · ELITE-MED.
Interparfums Inc · MICRO
ABS(ceo_total_comp) peer at $279K (Δ $4K heavier vs Innoviva, Inc.); FLOOR · PAR-MED vs this page's MODEST · MICRO · ELITE-MED.
Take Two Interactive Software Inc · MICRO
ABS(ceo_total_comp) peer at $280K (Δ $6K heavier vs Innoviva, Inc.); FLOOR · HIGH-MED vs this page's MODEST · MICRO · ELITE-MED.
Avadel Pharmaceuticals PLC · MICRO
ABS(ceo_total_comp) peer at $281K (Δ $6K heavier vs Innoviva, Inc.); FLOOR · ELITE-MED vs this page's MODEST · MICRO · ELITE-MED.
Universal Technical Institute Inc · MICRO
ABS(ceo_total_comp) peer at $283K (Δ $9K heavier vs Innoviva, Inc.); FLOOR · HIGH-MED vs this page's MODEST · MICRO · ELITE-MED.
Chemicals & Pharmaceuticals benchmark
Innoviva, Inc. stamps MODEST · MICRO · ELITE-MED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · MODEST
See where MODEST · MICRO packages sit on the national leaderboard after reading Innoviva, Inc..
Ratio primer · MODEST
Innoviva, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Innoviva, Inc. (CIK 1080014), FY2021. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.